|
ZBTB41 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.355170E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.960000E-04 |
| Normal-vs-Stage2 |
2.876600E-03 |
| Normal-vs-Stage3 |
2.646300E-04 |
| Normal-vs-Stage4 |
3.776100E-03 |
| Stage1-vs-Stage2 |
7.038600E-01 |
| Stage1-vs-Stage3 |
5.103400E-01 |
| Stage1-vs-Stage4 |
6.690600E-01 |
| Stage2-vs-Stage3 |
9.207000E-01 |
| Stage2-vs-Stage4 |
9.716600E-01 |
| Stage3-vs-Stage4 |
9.561800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.984100E-04 |
| Normal-vs-AfricanAmerican |
3.509200E-01 |
| Normal-vs-Asian |
1.630270E-04 |
| Caucasian-vs-AfricanAmerican |
1.344410E-01 |
| Caucasian-vs-Asian |
2.053800E-01 |
| AfricanAmerican-vs-Asian |
2.154200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.368420E-04 |
| Normal-vs-Female |
3.982100E-04 |
| Male-vs-Female |
3.912800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.844700E-03 |
| Normal-vs-Age(41-60Yrs) |
4.05359999999799E-05 |
| Normal-vs-Age(61-80Yrs) |
1.199950E-03 |
| Normal-vs-Age(81-100Yrs) |
1.536800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.159000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.908200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.617400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.484000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.106800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.261000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.770800E-01 |
| Classical-VS-Follicular |
8.640000E-03 |
| Classical-VS-Other |
2.514400E-01 |
| Classical-VS-Normal |
4.556700E-03 |
| Tall-VS-Follicular |
4.122400E-01 |
| Tall-VS-Other |
4.294000E-01 |
| Tall-VS-Normal |
6.241600E-03 |
| Follicular-VS-Other |
7.491000E-01 |
| Follicular-VS-Normal |
1.58246999999445E-05 |
| Other-VS-Normal |
2.991900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.73623999999428E-05 |
| Normal-vs-N1 |
4.008000E-04 |
| N0-vs-N1 |
6.910200E-01 |
|
|
